In melanoma model, napabucasin (STAT3 inhibitor) promotes apoptosis of MDSCs in human peripheral blood and mouse bone marrow, thereby enhancing antitumor immunity and prognosis [43]. The gene discussed is STAT3; the disease is melanoma.